
Keywords: AE; Adverse Event; AUC; Area Under the Curve; BIC; Bayesian information criterion; BP; Bisphosphonate; C0; Trough level; CT; Adjuvant chemotherapy; EVR; Everolimus; GEE; generalized estimating equation; HT; Adjuvant hormonotherapy; MDRD; Modification of D